PREOPERATIVE AND POSTOPERATIVE EVALUATION OF PROSTATE-SPECIFIC ANTIGEN IN LOCALIZED PROSTATIC-CANCER TREATED BY RADICAL PROSTATECTOMY

被引:0
|
作者
ZATTONI, F
PIAZZA, R
VIANELLO, R
GARBEGLIO, A
PAGANO, F
机构
关键词
PROSTATIC CARCINOMA; PROSTATE-SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Preoperative prostate-specific antigen (PSA) values were determined in 73 patients with clinically localized prostatic cancer and candidates for a radical procedure. Correlation of preoperative PSA with a final pathological stage was attempted. Only i n 44.8% of our 22 patients with organ-confined disease was the PSA value within the normal range; in 17.3% of cases PSA values were higher than 20 ng/ml. 18.2% of the patients with locally advanced disease showed normal PSA values, while 45.5% had concentrations above 20 ng/ml. In the case of lymph node involvement, PSA values were normal in 22.7% of the cases. Our data indicate that no strict relationship can be suggested between PSA and the final pathological stage and grading of the tumor in patients who underwent radical prostatectomy.
引用
下载
收藏
页码:99 / 101
页数:3
相关论文
共 50 条
  • [41] Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
    Cookson, MS
    Fleshner, NE
    Soloway, SM
    Fair, WR
    UROLOGY, 1997, 49 (06) : 887 - 893
  • [42] Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer
    Nelson, BA
    Shappell, SB
    Chang, SS
    Wells, N
    Farnham, SB
    Smith, JA
    Cookson, MS
    BJU INTERNATIONAL, 2006, 97 (06) : 1169 - 1172
  • [43] Long-term Outcomes of Open Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer in the Prostate-specific Antigen Era
    Dorin, Ryan P.
    Daneshmand, Siamak
    Lassoff, Mark A.
    Cai, Jie
    Skinner, Donald G.
    Lieskovsky, Gary
    UROLOGY, 2012, 79 (03) : 626 - 631
  • [44] The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml
    Bastide, C.
    Kuefer, R.
    Loeffler, M.
    de Petriconi, R.
    Gschwend, J.
    Hautmann, R.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 239 - 244
  • [45] Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: Relation to progression following radical prostatectomy
    Sauvageot, J
    Epstein, JI
    PROSTATE, 1998, 34 (01): : 29 - 33
  • [46] IMMUNOREACTIVE PROSTATE-SPECIFIC ACID-PHOSPHATASE IN PROSTATIC-CANCER
    KONTTURI, M
    VIHKO, P
    LUKKARINEN, O
    VIHKO, R
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 : 67 - 74
  • [47] Evaluation of human glandular kallikrein 2 and free prostate-specific antigen levels as predictors of biochemical recurrence after radical prostatectomy for localized prostate cancer
    Steuber, T
    Haese, A
    Vickers, AJ
    Becker, C
    Chun, FKH
    Karakiewicz, PI
    Scardino, PT
    Huland, H
    Lija, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 259 - 259
  • [48] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [49] Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk
    Inoue, Hitoshi
    Nishimura, Kensaku
    Hara, Tsuneo
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (09) : 884 - 884
  • [50] CONTRIBUTION OF BONE-SCINTIGRAPHY, PROSTATIC ACID-PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN TO THE MONITORING OF PROSTATIC-CANCER
    HETHERINGTON, JW
    SIDDALL, JK
    COOPER, EH
    EUROPEAN UROLOGY, 1988, 14 (01) : 1 - 5